FDA-Approved Semaglutide Options for Weight Loss Currently, the two semaglutide-based treatments approved for weight loss are: 1
This executive order directs drug costs in the U.S
The GLP-1R/GIPR/GCGR triple agonist showed 22.1% weight loss at 48 weeks in Phase 2 and may set a higher efficacy ceiling in Phase 3 (TRIUMPH trials)
14 Bloomberg, Nestl Courts People Taking Weight-Loss Drugs With Frozen Pizza, May 2024 15 The Wall Street Journal, Big Food Is Learning to Love Weight-Loss Drugs, October 2024 16 Food & Wine, 1 in 8 People in the U.S
GLP-1 medications are not a future trend
Unlike allopurinol, however, early in therapy probenecid can increase urinary uric acid, which could lead to the development of a kidney stone